News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,553 Results
Type
Article (41724)
Company Profile (266)
Press Release (686549)
Multimedia
Podcasts (85)
Webinars (20)
Section
Business (205031)
Career Advice (2027)
Deals (35602)
Drug Delivery (121)
Drug Development (81574)
Employer Resources (173)
FDA (16560)
Job Trends (14990)
News (347227)
Policy (32844)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2602)
Accelerated approval (42)
Adcomms (25)
Allergies (160)
Alliances (49680)
ALS (192)
Alzheimer's disease (1740)
Antibody-drug conjugate (ADC) (366)
Approvals (16877)
Artificial intelligence (593)
Autoimmune disease (222)
Automation (50)
Bankruptcy (366)
Best Places to Work (11655)
BIOSECURE Act (20)
Biosimilars (201)
Biotechnology (175)
Bladder cancer (177)
Brain cancer (63)
Breast cancer (685)
Cancer (5301)
Cardiovascular disease (449)
Career advice (1716)
Career pathing (39)
CAR-T (299)
CDC (53)
Celiac Disease (2)
Cell therapy (797)
Cervical cancer (41)
Clinical research (70316)
Collaboration (1888)
Company closure (4)
Compensation (1270)
Complete response letters (69)
COVID-19 (2725)
CRISPR (98)
C-suite (974)
Cystic fibrosis (148)
Data (7041)
Decentralized trials (3)
Denatured (26)
Depression (153)
Dermatology (57)
Diabetes (549)
Diagnostics (6831)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (292)
Drug pricing (194)
Drug shortages (29)
Duchenne muscular dystrophy (269)
Earnings (91108)
Editorial (60)
Employer branding (21)
Employer resources (152)
Events (118481)
Executive appointments (1031)
FDA (19981)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1619)
Gene editing (211)
Generative AI (51)
Gene therapy (653)
GLP-1 (1015)
Government (4703)
Grass and pollen (6)
Guidances (397)
Healthcare (18966)
HIV (73)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (271)
Immuno-oncology (80)
Indications (157)
Infectious disease (3037)
Inflammatory bowel disease (201)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (273)
Interviews (316)
IPO (16663)
IRA (50)
Job creations (3651)
Job search strategy (1429)
JPM (58)
Kidney cancer (18)
Labor market (92)
Layoffs (554)
Leadership (34)
Legal (7979)
Liver cancer (98)
Longevity (28)
Lung cancer (712)
Lymphoma (407)
Machine learning (52)
Management (59)
Manufacturing (918)
MASH (176)
Medical device (13931)
Medtech (14009)
Mergers & acquisitions (20091)
Metabolic disorders (1406)
mRNA (175)
Multiple sclerosis (172)
NASH (17)
Neurodegenerative disease (382)
Neuropsychiatric disorders (97)
Neuroscience (3126)
Neurotech (1)
NextGen: Class of 2026 (6532)
Non-profit (4541)
Now hiring (73)
Obesity (661)
Opinion (275)
Ovarian cancer (185)
Pain (227)
Pancreatic cancer (253)
Parkinson's disease (336)
Partnered (33)
Patents (552)
Patient recruitment (588)
Peanut (60)
People (59318)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (21920)
Phase 2 (30948)
Phase 3 (23054)
Pipeline (7101)
Policy (303)
Postmarket research (2575)
Preclinical (9300)
Press Release (64)
Prostate cancer (274)
Psychedelics (49)
Radiopharmaceuticals (302)
Rare diseases (996)
Real estate (5965)
Recruiting (70)
Regulatory (25025)
Reports (54)
Research institute (2418)
Resumes & cover letters (353)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (163)
Series A (268)
Series B (201)
Service/supplier (11)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (45)
Startups (3641)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (85)
The Weekly (57)
Vaccines (1054)
Venture capital (99)
Weight loss (420)
Women's health (109)
Worklife (19)
Date
Today (1)
Last 7 days (637)
Last 30 days (2540)
Last 365 days (29923)
2026 (7988)
2025 (30210)
2024 (35249)
2023 (40134)
2022 (51233)
2021 (55766)
2020 (54149)
2019 (46618)
2018 (35087)
2017 (32192)
2016 (31572)
2015 (37666)
2014 (31414)
2013 (26461)
2012 (28718)
2011 (29435)
2010 (27601)
Location
Africa (741)
Alabama (90)
Alaska (7)
Arizona (332)
Arkansas (13)
Asia (39601)
Australia (6486)
California (12250)
Canada (3506)
China (1226)
Colorado (522)
Connecticut (523)
Delaware (366)
Europe (85697)
Florida (1847)
Georgia (393)
Hawaii (3)
Idaho (62)
Illinois (957)
India (80)
Indiana (558)
Iowa (22)
Japan (485)
Kansas (129)
Kentucky (44)
Louisiana (38)
Maine (73)
Maryland (1482)
Massachusetts (8756)
Michigan (346)
Minnesota (679)
Mississippi (6)
Missouri (138)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (82)
New Jersey (3267)
New Mexico (28)
New York (3234)
North Carolina (1560)
North Dakota (8)
Northern California (6055)
Ohio (365)
Oklahoma (23)
Oregon (41)
Pennsylvania (2481)
Puerto Rico (26)
Rhode Island (51)
South America (1117)
South Carolina (76)
South Dakota (1)
Southern California (4816)
Tennessee (199)
Texas (1926)
United States (43416)
Utah (367)
Vermont (1)
Virginia (291)
Washington D.C. (80)
Washington State (982)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
728,553 Results for "cardia inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
April 2, 2026
·
4 min read
Pi-Cardia Receives FDA Breakthrough Device Designation for ShortCut™
Pi-Cardia Ltd. announced today it received Breakthrough Device Designation from the US Food and Drug Administration for ShortCut™ - the world’s first dedicated leaflet modification device facilitating valve-in-valve Transcatheter Aortic Valve Replacement (TAVR) procedures in patients at risk of coronary obstruction.
January 22, 2024
·
3 min read
Business
Pi-Cardia Hires Gary Gratson to Lead Global Commercialization
Pi-Cardia Ltd. announced it hired Gary Gratson to lead commercial operations for ShortCut™, the world’s first dedicated leaflet modification device to enable Transcatheter Aortic Valve Replacement in patients at risk of coronary obstruction.
December 11, 2023
·
3 min read
Press Releases
Pi-Cardia Receives FDA Market Clearance for ShortCut™
September 30, 2024
·
3 min read
Press Releases
BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT)
March 3, 2026
·
6 min read
Pi-Cardia Successfully Completes Enrollment in Pivotal Study for ShortCut™
Pi-Cardia Ltd. announced today the successful completion of its ShortCut™ Pivotal Study enrollment. ShortCut™ is the world’s first dedicated device designed to split the leaflets of pre-existing valves to enable safe Transcatheter Aortic Valve Replacement (TAVR) in patients at risk of coronary obstruction.
September 20, 2023
·
4 min read
Press Releases
Picard Medical, Inc. and SynCardia Systems LLC CEO to Present at CSI Focus D-HF 2025 in Frankfurt, Germany
December 4, 2025
·
2 min read
Press Releases
BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT)
February 3, 2026
·
3 min read
Press Releases
Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase
January 16, 2026
·
5 min read
Press Releases
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
March 25, 2026
·
3 min read
1 of 72,856
Next
